BDBM604302 US11661419, Example 51::US20230280220, Example 51

SMILES C[C@H](N1CCOCC1)C(=O)N(C)c1cc(C)c2[nH]c(nc2c1)-c1n[nH]c2C[C@]3(C)[C@H](Cc12)C3(F)F

InChI Key InChIKey=MIXWLMXNDOJNAK-NFLRMMDNSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 604302   

TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM604302(US11661419, Example 51 | US20230280220, Example 51)
Affinity DataIC50:  2nMAssay Description:1.0M HEPES Buffer pH 7.5 solution was prepared as follows: 238.3 g HEPES free acid (Sigma) and 800 mL of water were combined, and the mixture was sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM604302(US11661419, Example 51 | US20230280220, Example 51)
Affinity DataIC50:  2nMAssay Description:ITK activity was determined by measuring the effect of a test compound in an ITK enzyme assay. 1.0 M HEPES Buffer pH 7.5 solution was prepared as fol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent